Found 43 matching trials
Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV PHASE4 The rapidly progression of the disease in HIV-HCV co-infected patients just...
Show More Location
Hospital General de Alicante
Learn More & Join Trial
Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) PHASE2 This study is intended to evaluate if 12 or 24 weeks of treatment with GSK3...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in differ...
Show More Learn More & Join Trial
A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms PHASE3 The purpose of the study is to compare the efficacy and toxicity including ...
Show More Location
Dept of Hematology, Aalborg hospital
Learn More & Join Trial
Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers EARLY_PHASE1 This is a non-randomized, open-label study examining the safety and efficac...
Show More Location
University of Nebraska Medical Center
Learn More & Join Trial
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 PHASE4 The study aims to study the outcome of pharmacokinetics-adjusted dose ribav...
Show More Location
King Faisal Specialist Hospital & Research Centre
Learn More & Join Trial
Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients N/A The most important method to slow down and stop the liver disease progressi...
Show More Location
Beijing Ditan hospital,Capital Medical University
Learn More & Join Trial
Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues PHASE4 Antiviral therapy is the most important method to slow and stop the progres...
Show More Location
Beijing Ditan hospital,Capital Medical University
Learn More & Join Trial
Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection PHASE4 Patients with acute hepatitis C virus (HCV) infection usually become chroni...
Show More Location
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Learn More & Join Trial
Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients PHASE4 Our previous collaborative studies has developed a molecular diagnosis tool...
Show More Location
Kaohsiung Medical University Hospital
Learn More & Join Trial